Stock Analysis

At CHF237, Is Kuehne + Nagel International AG (VTX:KNIN) Worth Looking At Closely?

SWX:KNIN
Source: Shutterstock

Today we're going to take a look at the well-established Kuehne + Nagel International AG (VTX:KNIN). The company's stock received a lot of attention from a substantial price movement on the SWX over the last few months, increasing to CHF301 at one point, and dropping to the lows of CHF237. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Kuehne + Nagel International's current trading price of CHF237 reflective of the actual value of the large-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Kuehne + Nagel International’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

View our latest analysis for Kuehne + Nagel International

What Is Kuehne + Nagel International Worth?

Kuehne + Nagel International appears to be expensive according to our price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average. We’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 19.6x is currently well-above the industry average of 6.92x, meaning that it is trading at a more expensive price relative to its peers. In addition to this, it seems like Kuehne + Nagel International’s share price is quite stable, which could mean two things: firstly, it may take the share price a while to fall back down to an attractive buying range, and secondly, there may be less chances to buy low in the future once it reaches that value. This is because the stock is less volatile than the wider market given its low beta.

Can we expect growth from Kuehne + Nagel International?

earnings-and-revenue-growth
SWX:KNIN Earnings and Revenue Growth March 20th 2024

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Though in the case of Kuehne + Nagel International, it is expected to deliver a negative earnings growth of -8.4%, which doesn’t help build up its investment thesis. It appears that risk of future uncertainty is high, at least in the near term.

What This Means For You

Are you a shareholder? If you believe KNIN is currently trading above its peers, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. Given the risk from a negative growth outlook, this could be the right time to reduce your total portfolio risk. But before you make this decision, take a look at whether its fundamentals have changed.

Are you a potential investor? If you’ve been keeping tabs on KNIN for some time, now may not be the best time to enter into the stock. The price has climbed past its industry peers, in addition to a risky future outlook. However, there are also other important factors which we haven’t considered today, such as the track record of its management. Should the price fall in the future, will you be well-informed enough to buy?

So while earnings quality is important, it's equally important to consider the risks facing Kuehne + Nagel International at this point in time. Be aware that Kuehne + Nagel International is showing 3 warning signs in our investment analysis and 1 of those is potentially serious...

If you are no longer interested in Kuehne + Nagel International, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Valuation is complex, but we're helping make it simple.

Find out whether Kuehne + Nagel International is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.